docetaxel anhydrous has been researched along with quinone in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (quinone) | Trials (quinone) | Recent Studies (post-2010) (quinone) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 2,150 | 3 | 809 |
Protein | Taxonomy | docetaxel anhydrous (IC50) | quinone (IC50) |
---|---|---|---|
Dihydroorotate dehydrogenase | Schistosoma mansoni | 8.8 | |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 36.1 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 4.82 | |
Caspase-1 | Homo sapiens (human) | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellezza, I; Gatticchi, L; Grottelli, S; Mierla, AL; Minelli, A | 1 |
1 other study(ies) available for docetaxel anhydrous and quinone
Article | Year |
---|---|
α-Tocopheryl succinate pre-treatment attenuates quinone toxicity in prostate cancer PC3 cells.
Topics: Active Transport, Cell Nucleus; alpha-Tocopherol; Antioxidants; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Docetaxel; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Glutathione; Heme Oxygenase-1; Humans; Hydrogen Peroxide; Hydroquinones; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Paraquat; Prostatic Neoplasms; Protoporphyrins; RNA Interference; RNA, Small Interfering; Taxoids | 2014 |